All Stories

  1. Association of Thyroid Function Test Abnormalities and Thyroid Autoimmunity With Preterm Birth
  2. The role of molecular genetics in the clinical management of sporadic medullary thyroid carcinoma: A systematic review
  3. Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study
  4. Does a simple web-based intervention facilitate the articulation of patients’ unvoiced agenda for a consultation with their diabetologists? A qualitative study
  5. Utility of systematic TSHR gene testing in adults with hyperthyroidism lacking overt autoimmunity and diffuse uptake on thyroid scintigraphy
  6. Effect of perchlorate and thiocyanate exposure on thyroid function of pregnant women from South-West England: a cohort study
  7. Pregnancy on vandetanib in metastatic medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2B
  8. Maternal thyroid hormone insufficiency during pregnancy and risk of neurodevelopmental disorders in offspring: A systematic review and meta-analysis
  9. Raising awareness of Graves' orbitopathy with early warning cards
  10. Interpretation of thyroid scintigraphy is inconsistent among endocrinologists
  11. Bony changes in primary hyperparathyroidism
  12. Subclinical hypothyroidism: Should we treat?
  13. Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit
  14. A preconsultation web-based tool to generate an agenda for discussion in diabetes outpatient clinics to improve patient outcomes (DIAT): a feasibility study
  15. Changing trend in referral to secondary care specialist thyroid eye disease clinic following the Amsterdam declaration
  16. Current laboratory requirements for adrenocorticotropic hormone and renin/aldosterone sample handling are unnecessarily restrictive
  17. Thyroid Physiology and Thyroid Diseases in Pregnancy
  18. Iodine deficiency amongst pregnant women in South-West England
  19. Exploring the motivations of patients with type 2 diabetes to participate in clinical trials: a qualitative analysis
  20. A Follow-Up Study of the Prevalence of Valvular Heart Abnormalities in Hyperprolactinemic Patients Treated With Cabergoline
  21. Effectiveness of interventions to reduce ordering of thyroid function tests: a systematic review
  22. Iodine supplementation in pregnancy - is it time?
  23. Thyroid research: stepping forward
  24. Maternal thyroid function in pregnant women with a breech presentation in late gestation
  25. SOS1frameshift mutations cause pure mucosal neuroma syndrome, a clinical phenotype distinct from multiple endocrine neoplasia type 2B
  26. Maternal hypothyroxinaemia in pregnancy is associated with obesity and adverse maternal metabolic parameters
  27. Investigating hyperkalaemia in adults
  28. Correction: Linkage Analysis in Autoimmune Addison’s Disease: NFATC1 as a Potential Novel Susceptibility Locus
  29. Linkage Analysis in Autoimmune Addison’s Disease: NFATC1 as a Potential Novel Susceptibility Locus
  30. The authors' reply: Too early to dismiss the block & replace regime for Graves' disease
  31. Management of patients with Graves’ orbitopathy: initial assessment, management outside specialised centres and referral pathways
  32. Diagnosis of Graves' Orbitopathy (DiaGO): Results of a Pilot Study to Assess the Utility of an Office Tool for Practicing Endocrinologists
  33. Recurrent phaeochromocytoma along the laparoscopic portal sites
  34. Endocrinology
  35. An international survey of screening and management of hypothyroidism during pregnancy in Latin America
  36. TSH Levels and Risk of Miscarriage in Women on Long-Term Levothyroxine: A Community-Based Study
  37. Diagnosis and management of thyrotoxicosis
  38. Impact of Month of Birth on the Development of Autoimmune Thyroid Disease in the United Kingdom and Europe
  39. Block & replace regime versus titration regime of antithyroid drugs for the treatment of Graves’ disease: a retrospective observational study
  40. Abklärung einer Hypokaliämie
  41. RET genetic screening in patients with multiple endocrine neoplasia type 2 and medullary thyroid carcinoma: experience of the Exeter Molecular Genetics Laboratory
  42. Identification of Novel Genetic Loci Associated with Thyroid Peroxidase Antibodies and Clinical Thyroid Disease
  43. 2014 European Thyroid Association Guidelines for the Management of Subclinical Hypothyroidism in Pregnancy and in Children
  44. Screening and management of hypothyroidism in pregnancy: Results of an Asian survey
  45. Management of hyperthyroidism during pregnancy in Asia
  46. A Cross-Sectional Study of the Prevalence of Cardiac Valvular Abnormalities in Hyperprolactinemic Patients Treated With Ergot-Derived Dopamine Agonists
  47. Five-Year Follow-Up for Women With Subclinical Hypothyroidism in Pregnancy
  48. Preoperative Endocrine Function and Fluid Electrolyte Balance
  49. Investigating hypokalaemia
  50. A pilot randomised controlled trial of a preconsultation web-based intervention to improve the care quality and clinical outcomes of diabetes outpatients (DIAT)
  51. Telephone consultations in place of face to face out-patient consultations for patients discharged from hospital following surgery: a systematic review
  52. Management of patients in a combined thyroid eye clinic in secondary care
  53. Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists
  54. Should subclinical hypothyroidism diagnosed during pregnancy be treated with long-termL-thyroxine?
  55. A Meta-Analysis of Thyroid-Related Traits Reveals Novel Loci and Gender-Specific Differences in the Regulation of Thyroid Function
  56. Management of hypothyroidism in pregnancy: we must do better
  57. New guidelines for the management of hypothyroidism
  58. Amiodarone-induced thyrotoxicosis, an overview of UK management
  59. Adrenal Steroidogenesis after B Lymphocyte Depletion Therapy in New-Onset Addison's Disease
  60. Cost implications, deprivation and geodemographic segmentation analysis of non-attenders (DNA) in an established diabetic retinopathy screening programme
  61. Can the Retinal Screening Interval Be Safely Increased to 2 Years for Type 2 Diabetic Patients Without Retinopathy?
  62. Phaeochromocytoma
  63. Side Effects of Anti-Thyroid Drugs and Their Impact on the Choice of Treatment for Thyrotoxicosis in Pregnancy
  64. Management of Hyperthyroidism in Pregnancy: Results of a Survey among Members of the European Thyroid Association
  65. 2012 European Thyroid Association Guidelines for the Management of Familial and Persistent Sporadic Non-Autoimmune Hyperthyroidism Caused by Thyroid-Stimulating Hormone Receptor Germline Mutations
  66. Treatment and screening of hypothyroidism in pregnancy: results of a European survey
  67. Orbital decompression for Graves’ orbitopathy in England
  68. Treatment for primary hypothyroidism: current approaches and future possibilities
  69. Spontaneously resolving Addison's disease
  70. Pseudohypoaldosteronism type 2 presenting with hypertension and hyperkalaemia due to a novel mutation in the WNK4 gene
  71. A woman with episodic headaches, sweating, and palpitations
  72. Fetal Thyroid Hormone Level at Birth Is Associated with Fetal Growth
  73. Immunomodulation of New-Onset Addison Disease Using B Lymphocyte Depletion Therapy: Interim Analysis
  74. Iodine status of UK schoolgirls: a cross-sectional survey
  75. A meta-analysis of the associations between common variation in the PDE8B gene and thyroid hormone parameters, including assessment of longitudinal stability of associations over time and effect of thyroid hormone replacement
  76. Quality of life in thyroid eye disease: impact of quality of care
  77. Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy
  78. Thyroid and Pregnancy
  79. Suspected Spontaneous Reports of Birth Defects in the UK Associated with the Use of Carbimazole and Propylthiouracil in Pregnancy
  80. Thyroid hormone resistance in identical twins
  81. An elderly woman with recurrent episodes of confusion
  82. Addison Disease in Adults: Diagnosis and Management
  83. Prevalence and Relative Risk of Other Autoimmune Diseases in Subjects with Autoimmune Thyroid Disease
  84. Phosphodiesterase 8B Gene Polymorphism Is Associated with Subclinical Hypothyroidism in Pregnancy
  85. Phosphodiesterase 8B Gene Polymorphism Is Associated with Subclinical Hypothyroidism in Pregnancy
  86. The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey
  87. Addison’s disease
  88. Addison's disease
  89. Addison's disease
  90. Common Variation in theDIO2Gene Predicts Baseline Psychological Well-Being and Response to Combination Thyroxine Plus Triiodothyronine Therapy in Hypothyroid Patients
  91. Germline mutations in theCDKN1Bgene encoding p27Kip1are a rare cause of multiple endocrine neoplasia type 1
  92. Cigarette Smoking during Pregnancy Is Associated with Alterations in Maternal and Fetal Thyroid Function
  93. Pituitary apoplexy within a macroprolactinoma
  94. A Common Variation in Deiodinase 1 GeneDIO1Is Associated with the Relative Levels of Free Thyroxine and Triiodothyronine
  95. Management of hypothyroidism in adults
  96. R. Lorini, M. Maghnie, G. D’Annunzio, S. Loche, M. O. Savage (eds) Congenital endocrinopathies: new insights into endocrine diseases and diabetes
  97. Radioiodine treatment for benign thyroid disorders: results of a nationwide survey of UK endocrinologists
  98. The impact of thyroid eye disease upon patients’ wellbeing: a qualitative analysis
  99. Wide variation in surgical outcomes for acromegaly in the UK
  100. Carpopedal spasm in an elderly man: an unusual presentation of coeliac disease
  101. Analysis of gross deletions in theMEN1gene in patients with multiple endocrine neoplasia type 1
  102. Detection of Thyroid Dysfunction in Early Pregnancy: Universal Screening or Targeted High-Risk Case Finding?
  103. Influences of Age, Gender, Smoking, and Family History on Autoimmune Thyroid Disease Phenotype
  104. GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes
  105. Phenotypic Multiple Endocrine Neoplasia Type 2B, Without Endocrinopathy or RET Gene Mutation: Implications for Management
  106. What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves’ disease
  107. Analysis of Peripheral Blood T-Cell Subsets in Active Thyroid-Associated Ophthalmopathy: Absence of Effect of Octreotide-LAR on T-Cell Subsets in Patients with Thyroid-Associated Ophthalmopathy
  108. Detection of an MEN1 gene mutation depends on clinical features and supports current referral criteria for diagnostic molecular genetic testing
  109. Double-Blind, Placebo-Controlled Trial of Octreotide Long-Acting Repeatable (LAR) in Thyroid-Associated Ophthalmopathy
  110. Pituitary Apoplexy: A Review of Clinical Presentation, Management and Outcome in 45 Cases
  111. Severe hypothyroidism after thalidomide treatment
  112. CTLA4 exon 1 polymorphism, rheumatoid arthritis and autoimmune endocrinopathy
  113. Premature birth and low birth weight associated with nonautoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation
  114. Four pedigrees of the cation-leaky hereditary stomatocytosis class presenting with pseudohyperkalaemia. Novel profile of temperature dependence of Na+-K+ leak in a xerocytic form
  115. The emerging role of the CTLA-4 gene in autoimmune endocrinopathies
  116. CTLA4 gene and Graves’ disease: association of Graves’ disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism
  117. Socio-economic deprivation and diabetic foot ulcers: no strong association
  118. The Genetics of Autoimmune Thyroid Disease
  119. Screening for thyroid disease in pregnancy: an audit
  120. A race to the lab
  121. An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies
  122. Evidence for a Graves’ Disease Susceptibility Locus at Chromosome Xp11 in a United Kingdom Population1
  123. Evidence for a Graves' Disease Susceptibility Locus at Chromosome Xp11 in a United Kingdom Population
  124. Recent advances in the molecular genetics of congenital and acquired primary adrenocortical failure
  125. Evidence for a New Graves Disease Susceptibility Locus at Chromosome 18q21
  126. CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis
  127. Association Analysis of the Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) and Autoimmune Regulator-1 (AIRE-1) Genes in Sporadic Autoimmune Addison’s Disease1
  128. Association Analysis of the Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) and Autoimmune Regulator-1 (AIRE-1) Genes in Sporadic Autoimmune Addison's Disease
  129. Further Evidence for a Susceptibility Locus on Chromosome 20q13.11 in Families with Dominant Transmission of Graves Disease
  130. Concurrence of Pendred Syndrome, Autoimmune Thyroiditis, and Simple Goiter in One Family
  131. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy
  132. The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus
  133. A Common and Recurrent 13-bp Deletion in the Autoimmune Regulator Gene in British Kindreds with Autoimmune Polyendocrinopathy Type 1
  134. Cerebral Venous Sinus Thrombosis: A Late Sequel of Invasive Fibrous Thyroiditis
  135. Corticosteroid therapy in Riedel's thyroiditis.
  136. Adrenocorticotropin-secreting carcinoid tumour identified and treated 12 years after presentation with Cushing's syndrome.
  137. Hypothalamic adipsic syndrome: diagnosis and management